Geoffrey David Edwin Thomas
Plus aucun poste en cours
Profil
Geoffrey David Edwin Thomas worked as the CEO & Managing Director of Paragon Advisory Pty Ltd.
from 2011 to 2017.
He also worked as a Director at Hospira Adelaide Pty Ltd.
Additionally, he served as a Non-Executive Director at Invitrocue Ltd.
from 2019 to 2020.
Anciens postes connus de Geoffrey David Edwin Thomas
| Sociétés | Poste | Fin |
|---|---|---|
| INVITROCUE LIMITED | Directeur/Membre du Conseil | 02/03/2020 |
Paragon Advisory Pty Ltd.
 Paragon Advisory Pty Ltd. Investment ManagersFinance Paragon Advisory Pty Ltd. (Paragon) is an independent Australian private equity firm which was founded in 2002 to pursue buyouts, acquisitions and expansion-stage investments in companies throughout Australia. Based in Unley, the firm manages the Paragon Private Equity fund, backed by superannuation funds and high net-worth individuals, aiming to investing in companies where they can add value and create wealth with the other owners of the investee business. | Directeur Général | 27/09/2017 |
Hospira Adelaide Pty Ltd.
 Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Directeur/Membre du Conseil | 16/09/2006 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Hospira Adelaide Pty Ltd.
Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Commercial Services |
Invitrocue Ltd.
 Invitrocue Ltd. Medical/Nursing ServicesHealth Services Invitrocue Ltd. engages in the provision of bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The firm focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. The company was founded by Steven Fang Boon Sing and Hanry Yu in 2012 and is headquartered in Sydney, Australia. | Health Services |
Paragon Advisory Pty Ltd.
Paragon Advisory Pty Ltd. Investment ManagersFinance Paragon Advisory Pty Ltd. (Paragon) is an independent Australian private equity firm which was founded in 2002 to pursue buyouts, acquisitions and expansion-stage investments in companies throughout Australia. Based in Unley, the firm manages the Paragon Private Equity fund, backed by superannuation funds and high net-worth individuals, aiming to investing in companies where they can add value and create wealth with the other owners of the investee business. | Finance |
